Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-18 Purchase |
2022-01-20 6:37 pm |
Day One Biopharmaceuticals Inc. | DAWN | AI Day1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
106,862 | $14.52 | $1,551,909 | 9,484,638 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 8:08 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $17.1 | $171,018 | 2,366,718 (Indirect Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 06:04 am |
Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner |
297,273 | $18.49 | $5,496,869 | 6,120,124 (Indirect) |
View |
| 2021-12-03 Sale |
2021-12-07 06:01 am |
Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner |
110,209 | $18.1 | $1,994,530 | 6,417,397 (Indirect) |
View |
| 2021-12-01 Sale |
2021-12-03 7:19 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $17.22 | $172,242 | 2,376,718 (Indirect Direct) |
View |
| 2021-06-01 Purchase |
2021-06-03 4:42 pm |
Day One Biopharmaceuticals Inc. | DAWN | AI Day 1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
875,000 | $16 | $14,000,000 | 9,377,776 (Direct) |
View |
| 2021-06-01 Purchase |
2021-06-02 8:52 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
13,000 | $16 | $208,000 | 11,411,924 (Indirect Direct) |
View |
| 2021-06-01 Purchase |
2021-06-02 6:40 pm |
Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner |
500,000 | $16 | $8,000,000 | 991,396 (Indirect) |
View |
| 2021-06-01 Purchase |
2021-06-02 5:12 pm |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
13,000 | $16 | $208,000 | 10,735,645 (Direct) |
View |
| 2021-06-01 Purchase |
2021-06-01 9:51 pm |
Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director |
7,000 | $16 | $112,000 | 136,473 (Direct) |
View |
| 2021-06-01 Purchase |
2021-06-01 9:50 pm |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
5,000 | $16 | $80,000 | 68,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-18 Option Award |
2022-01-20 7:30 pm |
N/A 2032-01-17 |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
173,000 | $0 | 173,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 7:29 pm |
N/A 2032-01-17 |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
154,000 | $0 | 154,000 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 7:29 pm |
N/A 2032-01-17 |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
454,000 | $0 | 454,000 (Direct) |
View |
| 2021-12-21 Other |
2021-12-22 4:40 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
536,000 | $0 | 10,199,645 (Direct) |
View |
| 2021-12-08 Other |
2021-12-09 5:15 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
536,000 | $0 | 10,735,645 (Direct) |
View |
| 2021-10-22 Gift |
2021-12-03 7:19 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
1,000,000 | $0 | 2,376,718 (Direct) |
View |
| 2021-11-24 Other |
2021-11-29 5:30 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. 10% Owner |
801,138 | $0 | 8,011,380 (Direct) |
View |
| 2021-11-24 Other |
2021-11-29 5:16 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner |
57,224 | $0 | 6,584,830 (Indirect) |
View |
| 2021-08-16 Option Award |
2021-08-18 7:03 pm |
N/A 2031-08-15 |
Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director |
48,072 | $0 | 48,072 (Direct) |
View |
Ownership |
2021-08-18 7:02 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director |
0 | $0 | 0 (Direct) |
View |
| 2021-06-01 Conversion |
2021-06-03 4:42 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | AI Day 1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
17,005,552 | $0 | 9,377,776 (Direct) |
View |
| 2021-02-01 Option Award |
2021-06-02 8:52 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
211,279 | $0 | 11,411,924 (Indirect) |
View |
| 2021-06-01 Conversion |
2021-06-02 8:52 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
7,476,776 | $0 | 11,411,924 (Indirect) |
View |
| 2021-06-01 Conversion |
2021-06-02 6:40 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner |
8,502,776 | $0 | 991,396 (Indirect) |
View |
| 2021-06-01 Conversion |
2021-06-02 5:12 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
7,476,776 | $0 | 10,735,645 (Direct) |
View |
| 2021-05-26 Option Award |
2021-06-01 9:51 pm |
N/A 2031-05-25 |
Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director |
64,181 | $0 | 136,473 (Direct) |
View |
| 2021-05-26 Option Award |
2021-06-01 9:50 pm |
N/A 2031-05-25 |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
63,000 | $0 | 68,000 (Direct) |
View |
Ownership |
2021-05-26 9:55 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. Atlas Venture Opportunity Fund I L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Associates Opportunity I LLC Atlas Venture Associates Opportunity I L.P. 10% Owner |
0 | $0 | 8,502,776 (Direct) |
View |
Ownership |
2021-05-26 9:38 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Chair of the Board |
0 | $0 | 11,250,645 (Direct) |
View |
Ownership |
2021-05-26 9:06 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director |
0 | $0 | 138,066 (Direct) |
View |
Ownership |
2021-05-26 9:04 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director |
0 | $0 | 129,473 (Direct) |
View |
Ownership |
2021-05-26 9:03 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director |
0 | $0 | 137,610 (Direct) |
View |
Ownership |
2021-05-26 9:03 pm |
N/A 2031-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Gladstone Michael Director |
0 | $0 | 63,000 (Direct) |
View |
Ownership |
2021-05-26 9:01 pm |
N/A 2031-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
0 | $0 | 63,000 (Direct) |
View |
Ownership |
2021-05-26 9:00 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
0 | $0 | 2,579,785 (Direct) |
View |
Ownership |
2021-05-26 8:58 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
0 | $0 | 835,227 (Direct) |
View |
Ownership |
2021-05-26 8:56 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
0 | $0 | 3,291,972 (Direct) |
View |
Ownership |
2021-05-26 8:55 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD MILLENNIUM PHARMACEUTICALS INC 10% Owner |
0 | $0 | 6,470,382 (Indirect) |
View |
Ownership |
2021-05-26 8:45 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
0 | $0 | 10,722,645 (Direct) |
View |
Ownership |
2021-05-26 8:34 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | AI Day 1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
0 | $0 | 8,502,776 (Direct) |
View |